(Logo: http://photos.prnewswire.com/prnh/20110118/CG30384LOGO)
"I am extremely excited about the opportunities here at Zyga. In today's environment, success is determined by products that are clinically validated to address the unmet needs of clinicians, and we are committed to meeting that challenge. We are excited about the traction we are gaining in the market with the SImmetry Sacroiliac Joint Fusion System, and the early clinical study results from the GLYDER Facet Resurfacing System. " said Jim Bullock
According to Dave Stassen, Chairman of the Board of Zyga Technology, Inc., and managing director of Split Rock Partners, "We are very pleased that Jim has joined the team at Zyga. Jim has a phenomenal track record of creating value for start-up companies in the medical device industry. Jim has been involved in medical devices throughout his career and brings a great deal of energy, commercialization success and strategic experience to Zyga."
Sacroiliac joint dysfunction and facetogenic pain have been shown to be the source of pain for up to 20% & 30% of patients suffering from low back pain respectively. Patients who suffer from these conditions typically receive therapeutic injections which temporarily address the problem but require long-term repeat treatments. Traditional, open surgery has been performed to address these conditions but is limited in practice due to its complexity, high complication rate and generally poor outcomes.
About Zyga Technology, Inc.
Based in Minneapolis, MN, Zyga Technology, Inc. was founded to develop and market innovative, minimally invasive surgical solutions to treat conditions of the spine. Zyga has put together a team of engineers, marketing personnel, and management with significant experience developing medical devices for the spine industry.
SOURCE Zyga Technology, Inc.
